MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.atherosclerosis.2018.06.819

Медицинская библиотека · Atherosclerosis · 2018

Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia.

Alves Ana Catarina, Benito-Vicente Asier, Medeiros Ana Margarida, Reeves Kaajal, Martin Cesar, Bourbon Mafalda

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AMD AIMS: APOB mutations are a rare cause of familial hypercholesterolaemia (FH) and, until recently, routine genetic diagnosis only included the study of two small APOB fragments. In previous years, 5 novel functional mutations have been described in APOB fragments not routinely studied, our group having functionally characterized 2 of them. The main aim of this work was to identify and characterize novel alterations in APOB to assess the genetic cause of hypercholesterolemia in patients with a clinical diagnosis of FH.

METHODS

We performed next generation sequencing of 48 Portuguese clinical FH patients, who were apparently mutation negative. All variants found in APOB were annotated. For functional studies, LDL from index patients and relatives was separated and marked with FITC-LDL for flow cytometry assays in lymphocytes and U937 growth assays.

RESULTS

A total of 11 potential pathogenic variants were identified. Variants p.(Pro994Leu) and p.(Thr3826Met) in exons 19 and 26 were found in 4 patients, and in vitro analysis was performed for these variants. An exon 26 alteration (p.(Thr3826Met)) showed a decrease in binding and internalization of LDL, and in U937 growth assays that was similar to the effect with p.(Arg3527Gln). An alteration in exon 19 had a neutral effect.

CONCLUSIONS

The spectrum of functional alterations in APOB outside the fragments routinely screened is slowly growing. Screening of all 29 exons of APOB is advised for FH routine diagnosis, but functional characterization is necessary for pathogenicity assessment. It is expected that the number of patients with functional APOB mutations will increase in the near future.

Для цитирования: Alves Ana Catarina, Benito-Vicente Asier, Medeiros Ana Margarida, Reeves Kaajal, Martin Cesar, Bourbon Mafalda. Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia.. Atherosclerosis. 2018. DOI: 10.1016/j.atherosclerosis.2018.06.819.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.